Ouvrez la porte J, Génamique, Google Scholar, ISA (résumés scientifiques indiens), Base de données CAS (Chemical Abstract Services), CABI (Royaume-Uni), Index Copernic, Hinar, EBSCO, Répertoire des périodiques d'Ulrich, Pesticides botaniques , Résumés de mauvaises herbes, AgBiotechNet, Ressource VetMed, Résumés de physiologie des cultures, Abrégés d'agroforesterie, Résumés helminthologiques, Horticulture ornementale, Abrégés de phytogénétiques, Novelles and informations on the porc, Abrégés sur les sciences laitières, Basis der Données sur Landwirtschaftliche Wirtschaft, Basis für Parasitologie-Studien, CAB-Lebensläufe, Zoologisches Register, Neue und nachträgliche Informationen, Basis für Ernährungs- und Lebensmittelwissenschaften, Basis für biologische Forschung, Weltgesundheit, ABC Chimie, Zentrum des Wissenschaften,SCIMAGO ist ein Zug,der viele andere Charaktere verrät.
Kathryn R. McDonald, Esther Chilman, Michelle Barraclough, Rebecca Elliott and Iracema Leroi
Objective: Non-motor changes in Parkinson’s disease (PD) can include behavioural disturbances, such as apathy and impulse control disorders (ICDs). These behavioural probl..Voir plus»
Alessandro Hoffman
Primary Progressive Aphasia (PPA) is split into three archetypal subtypes, each of which is defined by a single aphasia symptom. Although other cognitive, behavioural, and motor..Voir plus»
Sami Al Kasab, Jennifer Takesaka, Pearce Korb and Jan Vlachy
Objective: Pharmacologically paralyzed patients frequently undergo continuous EEG monitoring (cEEG) to assess for seizures. However, cEEG is costly, consumes va..Voir plus»
Cheerag Sunar
Although fossil fuel sources are limited and likely to be depleted soon, current energy consumption is entirely dependent on them. Excessive use of fossil fuels not only deplete..Voir plus»
Freeman B, Wang J
Background: Newer agents targeting the androgen signaling pathway, including abiraterone acetate (Zytiga) and enzalutamide (Xtandi), have led to survival improv..Voir plus»
Fu Wen-yi, Zhang Ning and Yang Lili
Objective: To observe the efficacy of combining recombinant human tumour necrosis factor-Fc [rhTNFR:Fc ,etanercept] and methotrexate (MTX) in patients with disease-modifying ant..Voir plus»